Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism

Publisher： Karger

E-ISSN： 1664-5502|6|1|16-24

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.6, Iss.1, 2015-0, pp. : 16-24

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin II Type 1 Receptor Antagonism Attenuates Abnormalities in Dynamic Renal Blood Flow Autoregulation in Rats with Endotoxin-Induced Acute Kidney Injury

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 3, 2010-06 ,pp. : 200-208

Karger

Access to resources Recommend Favorite

Beneficial Effect of Combination Therapy with an Angiotensin II Receptor Antagonist and Angiotensin-Converting Enzyme Inhibitor on Overt Proteinuria in a Patient with Type 1 Diabetic Nephropathy

By  

Nephron, Vol. 86, Iss. 4, 2000-12 ,pp. : 529-530

Karger

Access to resources Recommend Favorite

Efficacy and Tolerability of Angiotensin II Type 1 Receptor Antagonists in Dialysis Patients Using AN69 Dialysis Membranes

By  

Kidney and Blood Pressure Research, Vol. 24, Iss. 1, 2001-01 ,pp. : 71-74

Karger

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease

By  

Nephron, Vol. 90, Iss. 3, 2002-02 ,pp. : 256-261

Karger

Access to resources Recommend Favorite

Angiotensin II Type 1 Receptor Gene Polymorphism in End-Stage Renal Disease

By  

Nephron, Vol. 92, Iss. 1, 2002-08 ,pp. : 51-55

Karger

Access to resources Recommend Favorite